Purchase Order 75N93021P01401
Award Date
9/20/21
Potential Completion Date
3/19/23
Potential Value
$1M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Ultima Genomics, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $340,025 firm fixed price purchase order to Illumina, Inc. to deliver one NextSEQ2000 genome sequencer to the Laboratory of Parasitic Diseases. The sequencer will support the laboratory's SARS-CoV-2 and other research efforts. As the prime contractor, Illumina will furnish the requested high-throughput sequencer from its San Diego, California location by the end date of October 25, 2021 to meet...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the NextSeq 1000 Sequencing System. The $213,150.00 contract supports NIAID's Vaccine Immunology Program's research into monoclonal antibodies and vaccines for infectious diseases such as HIV, influenza, Ebola, and SARS-CoV-2....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $23,084 purchase order to Novogene Corp Inc. to provide whole genome next-generation sequencing services for land sample analysis. The contract has a period of performance of one year from August 2025 through August 2026. The prime contractor Novogene Corp Inc. will perform the sequencing services at its facility located in Sacramento, California. The contract...
This $340,025 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Illumina, Inc. to deliver an Illumina NextSeq 2000 Sequencer or equivalent high-throughput next-generation sequencing system. The solicitation sought quotes for this sequencing equipment to increase NIAID's capacity for sequencing samples related to...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,021.25 firm fixed price purchase order to Illumina, Inc. to procure one mid-throughput next generation sequencing instrument or equal. The solicitation sought a sequencing instrument with flowcell options ranging from 100 million to 1.2 billion reads and an onboard bioinformatics server, to be delivered by December 28, 2023 to the Vaccine Research Center...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of NextSeq, MiSeq, and iSeq sequencing kits. The $96,390.00 award does not have a set-aside designation and is intended to support genomic research and analysis at the agency's Bethesda, MD location. Illumina has...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,236.05 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of Illumina Sequencing Kits and will be performed in San Diego, California. The award does not have a set-aside designation. Illumina has previously provided...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $953,700.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer, to provide a NOVASEQ 6000 sequencing system. The contract has no set-aside designation and was completed on September 29, 2017. Illumina has previously received prime contracts from various federal agencies, including the NIH, CDC, USDA, and VA, to supply...